In the News

Fecal transplants by pill noninferior to colonoscopy delivery

The primary outcome of the unblinded, randomized trial was the proportion of patients without recurrent Clostridium difficile infection 12 weeks after fecal transplant.

Online decision aid may help selection of biologics in IBD

In a survey, 41.3% of respondents with inflammatory bowel disease (IBD) said treatment efficacy was the most important attribute for a biologic, and 53.9% preferred subcutaneous administration at home over IV administration in a clinic.

Factors to predict Barrett's esophagus progression identified in a meta-analysis

Progression was found to be significantly associated with increasing age, male sex, smoking, and increasing segment length, with a low degree of heterogeneity.

MKSAP quiz: Follow-up after ED visit for gallstones

This month's quiz asks readers to determine the most appropriate follow-up for a 41-year-old woman who was diagnosed with gallstones after an ED visit 1 week ago.

Spotlight on drug side effects

One recent study looked at whether NSAID use was linked to incident pancreatic adenocarcinoma, while the other examined acetaminophen-induced hepatotoxicity.

Biosimilar approved for certain cases of breast, metastatic stomach cancer

The drug is the first FDA-approved biosimilar to treat breast or stomach cancer and the second FDA-approved biosimilar to treat cancer.